Research Tracker›Biomarker Atlas›Type 1 Diabetes›ZnT8 autoantibodies

ZnT8 autoantibodies in Type 1 Diabetes

ZnT8 autoantibodies belongs to the metabolic group of Type 1 Diabetes markers and is reported to be raised relative to the reference group of the cited comparison (T1D patients vs non-diabetic controls). The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. This entry summarises Bhola et al. 2021. Group-level associations like this do not translate into an individual diagnostic cut-off.

↑ ElevatedMetabolic

Summary

Direction in Type 1 Diabetes↑ Elevated — higher than in the comparison group
CategoryMetabolic
Compared againstT1D patients vs non-diabetic controls
SourceBhola et al. 2021 — doi:10.1186/s12902-021-00812-8
Condition atlasType 1 Diabetes Biomarker Atlas

Related Metabolic markers in Type 1 Diabetes

Full list: Type 1 Diabetes Biomarker Atlas.

Frequently asked questions

Is ZnT8 autoantibodies high or low in Type 1 Diabetes?

Elevated. Studies summarised in the OSMF atlas report higher ZnT8 autoantibodies in Type 1 Diabetes than in the reference group of the cited comparison (T1D patients vs non-diabetic controls). Source: Bhola et al. 2021.

Which test measures ZnT8 autoantibodies?

The atlas record does not list a standardised clinical test code (LOINC) for ZnT8 autoantibodies, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal ZnT8 autoantibodies result diagnostic of Type 1 Diabetes?

No. No single biomarker is diagnostic of Type 1 Diabetes. ZnT8 autoantibodies findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). ZnT8 autoantibodies in Type 1 Diabetes: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/type-1-diabetes/znt8-autoantibodies.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-03 · Page generated from type-1-diabetes.json · Browse: Type 1 Diabetes atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.